Gene · 8661
Papers4,269
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 4,269
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Computational inference of eIF4F complex function and structure in human cancers. | Proc Natl Acad Sci U S A | 2024 | 38266053 | PubTator, text mining | PubMed |
| BMP9-ID1 Pathway Attenuates N6-Methyladenosine Levels of CyclinD1 to Promote Cell Proliferation in Hepatocellular Carcinoma. | Int J Mol Sci | 2024 | 38256056 | PubTator, text mining | PubMed |
| METTL3 drives NSCLC metastasis by enhancing CYP19A1 translation and oestrogen synthesis. | Cell Biosci | 2024 | 38238831 | PubTator, text mining | PubMed |
| Correction to 'Translation reprogramming by eIF3 linked to glioblastoma resistance'. | NAR Cancer | 2024 | 38225939 | PubTator, text mining | PubMed |
| Emerging Targets for Systemic Treatment of Gastric Cancer: HER2 and Beyond. | J Gastric Cancer | 2024 | 38225765 | PubTator, text mining | PubMed |
| Akt enhances the vulnerability of cancer cells to VCP/p97 inhibition-mediated paraptosis. | Cell Death Dis | 2024 | 38218922 | PubTator, text mining | PubMed |
| The important regulatory roles of circRNA‑encoded proteins or peptides in cancer pathogenesis (Review). | Int J Oncol | 2024 | 38186313 | PubTator, text mining | PubMed |
| Translational enhancement of target endogenous mRNA in mammalian cells using programmable RNA-binding pentatricopeptide repeat proteins. | Sci Rep | 2024 | 38167853 | PubTator, text mining | PubMed |
| Comprehensive analysis of m6A reader YTHDF2 prognosis, immune infiltration, and related regulatory networks in hepatocellular carcinoma. | Heliyon | 2024 | 38163150 | PubTator, text mining | PubMed |
| Interactome Analysis Identifies the Role of BZW2 in Promoting Endoplasmic Reticulum-Mitochondria Contact and Mitochondrial Metabolism. | Mol Cell Proteomics | 2024 | 38154691 | PubTator, text mining | PubMed |
| Loss-of-function cancer-linked mutations in the EIF4G2 non-canonical translation initiation factor. | Life Sci Alliance | 2024 | 38129098 | PubTator, text mining | PubMed |
| Non-coding RNA-Mediated N6-Methyladenosine (m6A) deposition: A pivotal regulator of cancer, impacting key signaling pathways in carcinogenesis and therapy response. | Noncoding RNA Res | 2024 | 38075202 | PubTator, text mining | PubMed |
| Uncovering the non-histone interactome of the BRPF1 bromodomain using site-specific azide-acetyllysine photochemistry. | J Biol Chem | 2024 | 38072045 | PubTator, text mining | PubMed |
| Biological landscape and nanostructural view in development and reversal of oxaliplatin resistance in colorectal cancer. | Transl Oncol | 2024 | 38042134 | PubTator, text mining | PubMed |
| N6-Methyladenosine Methylation of mRNA in Cell Apoptosis. | Mol Neurobiol | 2024 | 38040996 | PubTator, text mining | PubMed |
| System-wide analysis of RNA and protein subcellular localization dynamics. | Nat Methods | 2024 | 38036857 | PubTator, text mining | PubMed |
| RNA-binding protein Nocte regulates Drosophila development by promoting translation reinitiation on mRNAs with long upstream open reading frames. | Nucleic Acids Res | 2024 | 38000373 | PubTator, text mining | PubMed |
| IGF2BP2 Drives Cell Cycle Progression in Triple-Negative Breast Cancer by Recruiting EIF4A1 to Promote the m6A-Modified CDK6 Translation Initiation Process. | Adv Sci (Weinh) | 2024 | 37983610 | PubTator, text mining | PubMed |
| Interconnections between m6A RNA modification, RNA structure, and protein-RNA complex assembly. | Life Sci Alliance | 2024 | 37935465 | PubTator, text mining | PubMed |
| Decoding m6A mRNA methylation by reader proteins in liver diseases. | Genes Dis | 2024 | 37692496 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8661/papers?page=8